MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Vascular Solutions Company Profile (NASDAQ:VASC)

Consensus Ratings for Vascular Solutions (NASDAQ:VASC) (?)
Ratings Breakdown: 2 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $43.25 (3.82% upside)

Analysts' Ratings History for Vascular Solutions (NASDAQ:VASC)
Show:
DateFirmActionRatingPrice TargetActions
4/27/2016Piper JaffrayReiterated RatingOverweight$44.00 -> $45.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/22/2016Canaccord GenuityReiterated RatingBuy$41.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/5/2014DA DavidsonInitiated CoverageBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/30/2014 forward)
Earnings History for Vascular Solutions (NASDAQ:VASC)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
7/19/2016        
4/25/2016Q116$0.23$0.25$38.37 million$39.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/21/2016Q415$0.27$0.33$37.53 million$38.09 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/20/2015Q315$0.25$0.27$36.41 million$37.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/21/2015Q215$0.25$0.29$35.59 million$37.60 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/21/2015Q115$0.18$0.21$33.38 million$34.61 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/3/2015Q414$0.18$0.23$32.82 million$33.60 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/21/2014Q314$0.20$0.15$31.10 million$31.90 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/22/2014Q214$0.18$0.20$30.43 million$30.70 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/22/2014Q114$0.18$0.16$29.91 million$29.91 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/4/2014Q413$0.19$0.22$28.61 million$29.10 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/22/2013Q313$0.07$0.19$27.10 million$28.01 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/23/2013Q2 2013$0.17$0.17$27.00 million$27.40 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/23/2013Q1 2013$0.15$0.16$26.51 million$26.10 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/5/2013Q4 2012$0.17$0.18$25.59 million$25.30 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/18/2012$0.15$0.16ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/24/2012$0.13$0.15ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/1/2012$0.13$0.13ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/25/2011$0.17$0.10ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/2/2011$0.12$0.13ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/19/2011$0.10$0.10ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/1/2011$0.12$0.12ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for Vascular Solutions (NASDAQ:VASC)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161$0.23$0.23$0.23
Q2 20161$0.30$0.30$0.30
Q3 20161$0.31$0.31$0.31
Q4 20161$0.34$0.34$0.34
(Data provided by Zacks Investment Research)
Dividend History for Vascular Solutions (NASDAQ:VASC)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for Vascular Solutions (NASDAQ:VASC)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
5/24/2016Howard RootCEOSell34,418$39.05$1,344,022.90View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/13/2016James HennenCFOSell11,785$38.12$449,244.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/13/2016Martin J EmersonDirectorSell20,000$37.93$758,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/28/2016John L ErbDirectorSell10,000$35.58$355,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/27/2016Howard RootCEOSell15,582$36.07$562,042.74View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/27/2016Timothy SlaytonInsiderSell2,994$36.72$109,939.68View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/29/2016Charmaine SuttonVPSell14,325$30.13$431,612.25View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/19/2015Jorge SaucedoDirectorSell7,715$33.45$258,066.75View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/4/2015Richard NigonDirectorSell8,000$32.40$259,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/2/2015Howard RootCEOSell18,062$32.03$578,525.86View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/26/2015Carrie PowersVPSell5,412$32.77$177,351.24View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/20/2015Jorge SaucedoDirectorSell2,285$38.00$86,830.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/23/2015Timothy SlaytonInsiderSell1,587$38.61$61,274.07View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/28/2015Richard NigonDirectorSell6,000$32.68$196,080.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/4/2015Howard RootCEOSell25,000$32.62$815,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/27/2015Carrie PowersVPSell6,000$34.90$209,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/24/2015James HennenCFOSell4,792$35.66$170,882.72View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/10/2015William RutsteinVPSell10,814$26.91$291,004.74View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/5/2015James HennenCFOSell11,301$27.62$312,133.62View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/5/2015Jorge SaucedoDirectorSell10,000$27.36$273,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/26/2014Richard NigonDirectorBuy3,000$25.80$77,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/14/2014Richard W KrampDirectorBuy1,475$23.69$34,942.75View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/24/2014Timothy SlaytonInsiderSell1,390$23.15$32,178.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/27/2014James HennenCFOSell10,000$25.42$254,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/25/2014Howard RootCEOSell50,000$24.74$1,237,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/25/2014Richard NigonDirectorBuy1,000$25.66$25,660.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/14/2014Howard RootCEOSell25,000$25.13$628,250.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/11/2014Paul O'connellDirectorSell2,000$24.43$48,860.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/10/2014William RutsteinVPSell27,782$23.80$661,211.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/28/2013James HennenCFOSell10,000$19.72$197,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/25/2013Jorge SaucedoDirectorSell2,000$19.70$39,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/26/2013Charmaine SuttonVPSell7,538$16.15$121,738.70View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/25/2013Howard RootCEOSell21,580$16.10$347,438.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/25/2013Howard RootCEOSell21,580$16.10$347,438.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/25/2013Paul O'connellDirectorSell30,000$16.11$483,300.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/17/2013Paul O'connellDirectorSell10,000$16.05$160,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/1/2013Richard NigonDirectorBuy3,000$15.57$46,710.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/26/2012Susan ChristianVPSell7,648$14.41$110,207.68View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for Vascular Solutions (NASDAQ:VASC)
DateHeadline
06/30/16 11:44 AMETF’s with exposure to Vascular Solutions, Inc. : June 30, 2016 -
06/28/16 01:31 PMVascular Solutions, Inc. :VASC-US: Earnings Analysis: Q1, 2016 By the Numbers : June 28, 2016 -
06/27/16 03:05 PMVascular Solutions, Inc. to Webcast Second Quarter Conference Call - [GlobeNewswire] - MINNEAPOLIS, June 27, 2016-- Vascular Solutions, Inc. today announced that it will host a live webcast of its second quarter conference call on Monday, July 25th at 3:30pm CDT. Vascular Solutions’ Chief ...
06/22/16 06:38 AMPharma Exec Beats Feds on Kickbacks Charge in Boston
06/08/16 10:14 AMVaricose Vein Treatment Market in North America and Europe Worth 289.7 Million USD by 2021
06/07/16 09:58 AMHemostats Market by Product Type, and Geography - Global Forecast to 2020
06/07/16 09:58 AMVascular Closure Devices Global Market - Forecast To 2022
06/05/16 06:57 PM[$$] Bringing Justice to Justice -
05/27/16 02:04 PMVascular Solutions, Inc. (NASDAQ:VASC) Closes At $38.85 - RealistInvestor.com - Vascular Solutions, Inc. (NASDAQ:VASC) Closes At $38.85RealistInvestor.comThe technical analysis of Vascular Solutions, Inc. (NASDAQ:VASC) stock highlights the stock is $2.90 points away +8.08% from its 50-day MA of $35.85. It is $6.46 or +20.01% away $32.29, the 200-day Moving Average (MA) of stock. Yesterday, the stock of ...Were Analysts Bullish Vascular Solutions, Inc. (NASDAQ:VASC) This Week?Franklin IndependentVascular Solutions, Inc. (NASDAQ:VASC) Current Deferred Tax Assets At $6 MillionsInvestor NewswireVascular Solutions, Inc. (NASDAQ:VASC) - Broker UpdateRisers & Fallersall 5 news articles »
05/24/16 02:05 PMVascular Solutions, Inc. (NASDAQ:VASC) Current Deferred Tax Assets At $6 Millions - Investor Newswire - Vascular Solutions, Inc. (NASDAQ:VASC) Current Deferred Tax Assets At $6 MillionsInvestor NewswireFor the year ended 2013-12-31, Vascular Solutions, Inc. (NASDAQ:VASC) recorded change of 1.537 millions in assets/liabilities. This came at $1.537 millions for the quarter closed 2013-12-31. For year ended 2013-12-31 'days sales' reported in ...and more »
05/24/16 02:05 PMEarnings Review and Stock Rundown for Vascular Solutions, Inc. (NASDAQ:VASC) - Wall Street Hints and News - Earnings Review and Stock Rundown for Vascular Solutions, Inc. (NASDAQ:VASC)Wall Street Hints and NewsInvestors and analysts will be paying close attention when the company posts earnings results. Earnings numbers can provide insight into a company's overall profitability. Covering equity analysts are expecting Vascular Solutions, Inc. (NASDAQ:VASC) to ...and more »
05/21/16 01:25 PMBBCS Software System Selected by Vascular Solutions for Freeze-Dried Plasma Development Program - PR Web (press release) - BBCS Software System Selected by Vascular Solutions for Freeze-Dried Plasma Development ProgramPR Web (press release)Blood Bank Computer Systems, Inc. (BBCS) today announced that Vascular Solutions, Inc. (Nasdaq: VASC) has selected BBCS's ABO Express software system to support the development of Vascular Solutions' RePlas™ freeze-dried plasma product.and more »
05/21/16 01:25 PMVascular Solutions : BBCS Software System Selected by Vascular Solutions for Freeze-Dried Plasma Development Program - About Vascular Solutions Vascular Solutions, Inc. is an innovative medical device company that focuses on developing unique clinical solutions for coronary and peripheral vascular procedures. The company has launched more than 100 products that are sold to ...
05/20/16 01:49 PMBBCS Software System Selected by Vascular Solutions for Freeze-Dried Plasma Development Program - Virtual-Strategy Magazine - BBCS Software System Selected by Vascular Solutions for Freeze-Dried Plasma Development ProgramVirtual-Strategy MagazineBlood Bank Computer Systems, Inc. (BBCS) today announced that Vascular Solutions, Inc. (Nasdaq: VASC) has selected BBCS's ABO Express software system to support the development of Vascular Solutions' RePlas™ freeze-dried plasma product.and more »
05/19/16 01:24 PMVascular Solutions Inc. (VASC) is Trading Higher on Unusual Volume for May 16 - Equities.com - Vascular Solutions Inc. (VASC) is Trading Higher on Unusual Volume for May 16Equities.comVascular Solutions Inc. (VASC) experienced unusually high volume on May. 16, as the stock gained 3.3% to a closing price of $39.48. The stock saw 263,903 shares trade hands over the course of the day on 2,458 trades. Given that the stock's average ...Vascular Solutions Incorporated (NASDAQ:VASC) Shorted Shares Increased 14.58% After Market SellingFranklin IndependentWere Analysts Bearish Vascular Solutions, Inc. (NASDAQ:VASC) This Week?Wall Street Hints and NewsVascular Solutions, Inc. (NASDAQ:VASC) Updated Broker Price TargetsShare Trading Newsall 4 news articles »
05/11/16 07:22 AMConsensus Rating Review for Vascular Solutions, Inc. (NASDAQ:VASC) - B.O.D.Y Confidential - Consensus Rating Review for Vascular Solutions, Inc. (NASDAQ:VASC)B.O.D.Y ConfidentialEquity research analysts currently have a consensus rating of 1.5 on shares of Vascular Solutions, Inc. (NASDAQ:VASC). Sell-side analysts will typically rate a company's stock based on extensive research. These ratings usually translate into a Buy ...and more »
05/10/16 07:56 AMVascular Solutions, Inc. (NASDAQ:VASC) Accounts Payable Is $4.55 - Investor Newswire - Vascular Solutions, Inc. (NASDAQ:VASC) Accounts Payable Is $4.55Investor NewswireVascular Solutions, Inc. (NASDAQ:VASC) posted accounts payable of $4.55 millions for the year ended 2016-03-31. For the quarter ended 2016-03-31 it stood at $4.55 millions. At the close of the year ended 2016-03-31, the change in accounts payable was ...and more »
05/04/16 06:35 AMAverage Analyst Rating for Vascular Solutions, Inc. (NASDAQ:VASC) - B.O.D.Y Confidential - Average Analyst Rating for Vascular Solutions, Inc. (NASDAQ:VASC)B.O.D.Y ConfidentialWall Street analysts have provided an average broker recommendation of 1.5 on Vascular Solutions, Inc. (NASDAQ:VASC) shares. The rating is determined by using the average of all analyst recommendations taken into consideration by Zacks Research.and more »
05/03/16 07:26 AMAccounts Payable Update From Vascular Solutions, Inc. (NASDAQ:VASC) - Investor Newswire - Accounts Payable Update From Vascular Solutions, Inc. (NASDAQ:VASC)Investor NewswireAt the close of fiscal 2015-12-31, the accounts payable change forVascular Solutions, Inc. (NASDAQ:VASC) was $1.063 millions. For the quarter ended 2015-12-31 it came in at $1.063 millions. For the fiscal ended 2015-12-31, the current deferred tax ...
05/02/16 04:38 PMVASCULAR SOLUTIONS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders -
05/02/16 07:55 AMBroker Outlook For The Week Ahead: Vascular Solutions, Inc. (NASDAQ:VASC) - Share Trading News - Broker Outlook For The Week Ahead: Vascular Solutions, Inc. (NASDAQ:VASC)Share Trading News12/12/2013 – Vascular Solutions, Inc. had its “buy” rating reiterated by analysts at Feltl & Co.. They now have a USD 23 price target on the stock. The share price of Vascular Solutions, Inc. (NASDAQ:VASC) was down -0.46% during the last trading ...
04/30/16 07:50 AMVascular Solutions, Inc. (NASDAQ:VASC) Is Trading Down – Insiders Are Selling - There has been some selling insider activity on Vascular Solutions, Inc. recently. John L. Erb, Director let go of $355,800 worth of shares at an average price of $35.58 on April 28th. That brings Erb’s holdings to $366,687 per an SEC filing yesterday.
04/29/16 08:34 AMVascular Solutions Inc. (VASC) Drops 5.21% on April 27 - Equities.com - Vascular Solutions Inc. (VASC) Drops 5.21% on April 27Equities.comVascular Solutions Inc. (VASC) was one of the Russell 2000's biggest losers for Wednesday April 27 as the stock slid 5.21% to $35.13, a loss of $-1.93 per share. Starting at an opening price of $36.72 a share, the stock traded between $35.05 and $37.00 ...and more »
04/28/16 12:55 PMETF’s with exposure to Vascular Solutions, Inc. : April 28, 2016 -
04/27/16 09:27 AMVascular Solutions, Inc. :VASC-US: Earnings Analysis: Q1, 2016 By the Numbers -
04/26/16 08:50 AMBRIEF-Vascular Solutions Q1 adjusted earnings per share $0.25 - Reuters - BRIEF-Vascular Solutions Q1 adjusted earnings per share $0.25ReutersApril 25 Vascular Solutions Inc : * Q1 adjusted earnings per share $0.25. * Q1 revenue $39.4 million versus i/b/e/s view $38.4 million. * Sees fy 2016 adjusted earnings per share $1.19 to $1.23. * Sees fy 2016 revenue up 12 percent. * Sees fy 2016 ...
04/26/16 08:50 AMVascular Solutions, Inc. (NASDAQ:VASC) Accounts Payable Stood At $5.83 Millions For The Year - Investor Newswire - Vascular Solutions, Inc. (NASDAQ:VASC) Accounts Payable Stood At $5.83 Millions For The YearInvestor NewswireThe difference in accounts payable of Vascular Solutions, Inc. (NASDAQ:VASC) at the close of fiscal 2015-12-31 was $1.063 millions. For the quarterly period ended 2015-12-31 difference in accounts payable was $1.063 millions. For the fiscal 2015-12-31, ...and more »
04/26/16 08:50 AMVASCULAR SOLUTIONS : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q) - Vascular Solutions, Inc. (we, us or Vascular) is an innovative medical device company focused on bringing clinically advanced solutions to the market for treating coronary and peripheral vascular disease. As a vertically-integrated medical device company ...
04/26/16 12:09 AMEdited Transcript of VASC earnings conference call or presentation 25-Apr-16 8:30pm GMT -
04/25/16 04:02 PMVascular Solutions beats by $0.02, beats on revenue -
04/25/16 03:53 PMVascular Solutions reports 1Q loss -
04/25/16 03:19 PMVASCULAR SOLUTIONS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Ex -
04/25/16 03:05 PMVascular Solutions Reports First Quarter Results - [GlobeNewswire] - Revenue increased 14% to $39.4 million, exceeding the top end of guidance Adjusted EPS increased 19% to $0.25, exceeding the top end of guidance Raising 2016 revenue guidance to $163- $166 million, representing ...
04/25/16 08:36 AMAfter Last Week What Do Analysts Think Of Vascular Solutions, Inc. (NASDAQ:VASC) - Share Trading News - Web Breaking NewsAfter Last Week What Do Analysts Think Of Vascular Solutions, Inc. (NASDAQ:VASC)Share Trading NewsVascular Solutions, Inc. is a medical device company, which creates minimally invasive medical devices and then delivers these products and services to physicians through its direct domestic sales force and its international distribution network. It ...Is Selling Vascular Solutions, Inc. Here a Winning Strategy?The PostVascular Solutions, Inc. (VASC) Shares Sold by Royce & Associates LLCWeb Breaking Newsall 4 news articles »
04/25/16 08:36 AMHost Live Webcast: Vascular Solutions, Inc. (VASC) - share market updates (press release) - Host Live Webcast: Vascular Solutions, Inc. (VASC)share market updates (press release)Shares of Vascular Solutions, Inc. (NASDAQ:VASC) ended Friday session in red amid volatile trading. The shares closed down -0.82 points or -2.14% at $37.50 with 117,662 shares getting traded. Post opening the session at $38.20, the shares hit an ...
04/25/16 06:07 AMQ1 2016 Vascular Solutions Inc Earnings Release - After Market Close -
04/24/16 07:50 AMIs Selling Vascular Solutions, Inc. Here a Winning Strategy? - The Post - Web Breaking NewsIs Selling Vascular Solutions, Inc. Here a Winning Strategy?The PostThe stock of Vascular Solutions, Inc. (NASDAQ:VASC) is a huge mover today! The stock decreased 2.14% or $0.82 on April 22, hitting $37.5. About 117,662 shares traded hands or 2.11% up from the average. Vascular Solutions, Inc. (NASDAQ:VASC) has ...Vascular Solutions, Inc. (VASC) Shares Sold by Royce & Associates LLCWeb Breaking NewsVascular Solutions Incorporated (NASDAQ:VASC) Shorted Shares Decreased By 11.18%CCH Daily Newsall 3 news articles »
04/22/16 08:54 AMVascular Solutions, Inc. (NASDAQ:VASC) Share Rating Recap - The Post - Vascular Solutions, Inc. (NASDAQ:VASC) Share Rating RecapThe PostShares of Vascular Solutions, Inc. (NASDAQ:VASC) are tracked by analysts as well as crowd investors. Research from Beta Systems keeps track of crowd sourced sentiment and provides consensus stock ratings. The rating information comes mainly from ...and more »
04/21/16 08:57 AMVascular Solutions, Inc. (NASDAQ:VASC) Has Been Given An ABR Of 1.5 - Investor Newswire - Vascular Solutions, Inc. (NASDAQ:VASC) Has Been Given An ABR Of 1.5Investor NewswireAnalysts have a positive outlook on Vascular Solutions, Inc. (NASDAQ:VASC) stock. As of 2016-04-20, the stock has been placed an ABR of 1.5. This number comes on a scale of 1 to 5, where one suggests a strong buy call and five indicates Strong Sell.and more »
04/21/16 08:57 AMSettle or Fight FDA/DOJ Off-Label Use Allegations? WSJ Editorial Looks at Vascular Solutions Trial Win and Asks What's Next? - In an editorial this weekend entitled “No Justice for Business,” The Wall Street Journal hailed a recent trial win by medical device maker Vascular Solutions, Inc. (VSI) as a “victory for common sense and the First Amendment” as it “will now ...
04/18/16 03:11 PMVascular Solutions, Inc.: Leads amongst peers with strong fundamentals -
04/18/16 08:59 AMHealthcare Gainers: Navidea Biopharmaceuticals, Inc (NYSEMKT:NAVB), Vascular Solutions Inc. (NASDAQ:VASC ... - KC Register - Healthcare Gainers: Navidea Biopharmaceuticals, Inc (NYSEMKT:NAVB), Vascular Solutions Inc. (NASDAQ:VASC ...KC RegisterVascular Solutions Inc. (NASDAQ:VASC) initiated a nationwide recall of Guardian II hemostasis valves used in catheterization procedures. Specific lots of the products have been recalled because they pose an increased risk of air leakage that may lead ...
04/18/16 08:59 AMWhat to Expect from Vascular Solutions, Inc. (VASC) EPS? - RiversideGazette.com - What to Expect from Vascular Solutions, Inc. (VASC) EPS?RiversideGazette.comWall Street await Vascular Solutions, Inc. (NASDAQ:VASC) to release earnings on April, 19. Analysts forecast EPS of $0.23, up exactly $0.02 or 9.52% from 2014's $0.21 EPS. The expected VASC's profit could reach $4.46 million giving the stock 41.33 P/E ...Analysts Set $38.50 Target Price for Vascular Solutions, Inc. (NASDAQ:VASC)The Vista Voiceall 2 news articles »
04/17/16 07:25 AMVascular Solutions, Inc. (NASDAQ:VASC) Analyst Recommendation Outlook - Clinton Financial - Vascular Solutions, Inc. (NASDAQ:VASC) Analyst Recommendation OutlookClinton FinancialThere are 2 analysts providing ratings for Vascular Solutions, Inc. (NASDAQ:VASC). 1 have given the stock a “Strong Buy”, 1 rate it a “Buy”, 0 are rating the stock a Hold, and 0 are recommending “Sell”. Every recommendation can be mapped to an integer ...and more »
04/15/16 11:34 PM[$$] No Justice for Business -
04/08/16 03:05 PMVascular Solutions, Inc. Issues Recall of Guardian® II Hemostasis Valves - [GlobeNewswire] - MINNEAPOLIS, April 08, 2016-- On March 3, 2016, Vascular Solutions, Inc., initiated a nationwide recall of Guardian II hemostasis valves used in catheterization procedures. Specific lots of the products ...
04/04/16 03:05 PMVascular Solutions, Inc. to Webcast First Quarter Conference Call - [GlobeNewswire] - MINNEAPOLIS, April 04, 2016-- Vascular Solutions, Inc. today announced that it will host a live webcast of its first quarter conference call on Monday, April 25th at 3:30pm CDT. Vascular Solutions’ Chief ...
04/01/16 03:30 PMVascular Solutions to Present at the 15th Annual Needham Healthcare Conference - [GlobeNewswire] - MINNEAPOLIS, April 01, 2016-- Vascular Solutions, Inc. today announced that the Company is scheduled to present at the 15 th Annual Needham Healthcare Conference in New York on Tuesday, April 12 th at ...
03/28/16 03:23 PMVASCULAR SOLUTIONS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhib -
03/04/16 03:19 PMVASCULAR SOLUTIONS INC Files SEC form 8-K, Change in Directors or Principal Officers -
About Vascular Solutions

Vascular Solutions logoVascular Solutions, Inc. is a medical device company, which creates minimally invasive medical devices and then delivers these products and services to physicians through its direct domestic sales force and its international distribution network. It offers products and services in three categories: Catheter products, which consist of catheters used in minimally invasive medical procedures for the treatment of vascular conditions, such as GuideLiner and Pronto extraction catheters and includes micro-introducer kits for gaining percutaneous access to the vasculature; Hemostat products, which consist of the D-Stat Dry hemostat to control surface bleeding, D-Stat Flowable for preventing bleeding in subcutaneous pockets, Accumed wrist positioning splints and Vasc Band inflatable compression bands, and Vein products, which consist of the Vari-Lase endovenous laser for the treatment of varicose veins and a reprocessing service for the ClosureFAST radiofrequency vein ablation catheter.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Medical Appliances & Equipment
  • Sub-Industry: Health Care Supplies
  • Exchange: NASDAQ
  • Symbol: VASC
  • CUSIP: 92231M10
Key Metrics:
  • Previous Close: $41.66
  • 50 Day Moving Average: $39.03
  • 200 Day Moving Average: $33.24
  • P/E Ratio: 91.16
  • P/E Growth: 1.59
  • Market Cap: $723.68M
  • Current Quarter EPS Consensus Estimate: $1.21 EPS
Additional Links:
Vascular Solutions (NASDAQ:VASC) Chart for Thursday, June, 30, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha